miR-93-5p

Mihnea P Dragomir1,2,3,4,5, Enrique Fuentes-Mattei1, Melanie Winkle6

  • 1Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center (MDACC), Houston, Texas, USA.

概括

研究人员将miR-93-5p确定为败血症中的关键微RNA. 抑制miR-93-5p在败血症模型中改善了生存率,为这种致命疾病提供了潜在的新治疗策略.